Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Botulinum Toxin Companies

Botulinum toxin, commonly known as Botox, is a neurotoxic protein used for various medical and cosmetic applications. Several companies are involved in the development, production, and distribution of botulinum toxin products. These products are primarily used for therapeutic and aesthetic purposes, including the treatment of various medical conditions and cosmetic procedures.

*Disclaimer: List of key companies in no particular orderLatest Botulinum toxin Companies Update

Sep 2023: The US Food and Drug Administration (FDA) has received resubmitted petitions from Hugel Inc., a biopharmaceutical business based in South Korea, regarding the product clearance of its botulinum toxin preparations "Letybo" in 50 and 100 units for the treatment of glabellar lines. The company applied to the FDA in October of last year for approval of the product for these two medications, and in April of this year, they received a comprehensive response letter. Hugel claims that the business has returned the application after making the required improvements to certain data, paperwork, and facility equipment following FDA regulations. After an estimated six months of examination, the company hopes to confirm the product's clearance status in the first half of the following year.

Sep 2023: According to a recent announcement from AbbVie, a late-stage trial of its novel combination medication for the treatment of a kind of blood cancer could not significantly raise patient survival rates without worsening the illness. A relapsed multiple myeloma that had undergone two or more prior therapies was being studied in patients using AbbVie's Venclyxto in combination with the steroid dexamethasone. While the results were not statistically significant, the combination of AbbVie and dexamethasone improved the median progression-free survival time to 9.9 months, as opposed to 5.8 months for a mix of Bristol-Myers Squibb's (BMY.N) Pomalyst and dexamethasone. In contrast to 35% of the individuals treated with the Pomalyst-dexamethasone combination, the business said that 62% of patients treated with the combo therapy demonstrated full elimination of tumors or reduced tumor size.

List of Botulinum toxin Key companies in the market

AbbVie Inc

Eisai Co., Ltd.

Evolus Inc

Galderma

Hugel, Inc.

Hugh Source International Ltd

Botulinum Toxin Market Highlights:

Botulinum Toxin Market Size

Botulinum Toxin Market Trends

Botulinum Toxin Market Analysis

Botulinum Toxin Market Share

Botulinum Toxin Market Highlights:

Botulinum Toxin Market Trends

Botulinum Toxin Market Analysis

Botulinum Toxin Market Share

Botulinum Toxin Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.